Seer, Inc. Hits New 52-Week Low at USD 1.62 Amid Declining Performance

Seer, Inc. (California), a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 1.62 as of July 1, 2026. This decline marks a significant downturn for the stock, which has experienced a one-year performance drop of 9.94%, contrasting sharply with the S&P 500's gain of 20.74% during the same period. The company's market capitalization stands at USD 94 million, reflecting its microcap status. Seer, Inc. has reported a challenging financial landscape, with a return on equity of -28.38% and a price-to-book ratio of 0.36, indicating potential undervaluation relative to its assets. The inventory turnover ratio has also hit a low of 1.03 times, suggesting inefficiencies in managing inventory. Additionally, the company has faced rising raw material costs, which increased by 28.85% year-over-year. With cash and equivalents at a low of USD 352.57 million, the financial metrics indicate a period of difficulty for Seer, Inc. as it navigates through these challenges in the competitive biotechnology landscape.